The global Immunocell Therapy market was valued at US$ 1876 million in 2023 and is anticipated to reach US$ 4413.7 million by 2030, witnessing a CAGR of 13.0% during the forecast period 2024-2030.

Immunocell Therapy Market

Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Immunocell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunocell Therapy.

Report Scope

The Immunocell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunocell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immunocell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immunocell Therapy Market Report

Report Metric	Details
Report Name	Immunocell Therapy Market
Accounted market size in 2023	US$ 1876 million
Forecasted market size in 2030	US$ 4413.7 million
CAGR	13.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Chimeric Antigen Receptor (CAR) T Cell Therapy Natural Killer (NK) Cell Therapy Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunocell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Immunocell Therapy Market growing?

Ans: The Immunocell Therapy Market witnessing a CAGR of 13.0% during the forecast period 2024-2030.

What is the Immunocell Therapy Market size in 2030?

Ans: The Immunocell Therapy Market size in 2030 will be US$ 4413.7 million.

Who are the main players in the Immunocell Therapy Market report?

Ans: The main players in the Immunocell Therapy Market are Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline), Sorrento Therapeutics(Pipeline), Mustang Bio(Pipeline), Bluebird Bio(Pipeline), Cellectis(Pipeline), Allogene Therapeutics(Pipeline), Celyad(Pipeline)

What are the Application segmentation covered in the Immunocell Therapy Market report?

Ans: The Applications covered in the Immunocell Therapy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Immunocell Therapy Market report?

Ans: The Types covered in the Immunocell Therapy Market report are Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunocell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Chimeric Antigen Receptor (CAR) T Cell Therapy

1.2.3 Natural Killer (NK) Cell Therapy

1.2.4 Others

1.3 Market by Application

1.3.1 Global Immunocell Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immunocell Therapy Market Perspective (2019-2030)

2.2 Immunocell Therapy Growth Trends by Region

2.2.1 Global Immunocell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immunocell Therapy Historic Market Size by Region (2019-2024)

2.2.3 Immunocell Therapy Forecasted Market Size by Region (2025-2030)

2.3 Immunocell Therapy Market Dynamics

2.3.1 Immunocell Therapy Industry Trends

2.3.2 Immunocell Therapy Market Drivers

2.3.3 Immunocell Therapy Market Challenges

2.3.4 Immunocell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immunocell Therapy Players by Revenue

3.1.1 Global Top Immunocell Therapy Players by Revenue (2019-2024)

3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Immunocell Therapy Revenue

3.4 Global Immunocell Therapy Market Concentration Ratio

3.4.1 Global Immunocell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunocell Therapy Revenue in 2023

3.5 Immunocell Therapy Key Players Head office and Area Served

3.6 Key Players Immunocell Therapy Product Solution and Service

3.7 Date of Enter into Immunocell Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Immunocell Therapy Breakdown Data by Type

4.1 Global Immunocell Therapy Historic Market Size by Type (2019-2024)

4.2 Global Immunocell Therapy Forecasted Market Size by Type (2025-2030)

5 Immunocell Therapy Breakdown Data by Application

5.1 Global Immunocell Therapy Historic Market Size by Application (2019-2024)

5.2 Global Immunocell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immunocell Therapy Market Size (2019-2030)

6.2 North America Immunocell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Immunocell Therapy Market Size by Country (2019-2024)

6.4 North America Immunocell Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immunocell Therapy Market Size (2019-2030)

7.2 Europe Immunocell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Immunocell Therapy Market Size by Country (2019-2024)

7.4 Europe Immunocell Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immunocell Therapy Market Size (2019-2030)

8.2 Asia-Pacific Immunocell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Immunocell Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Immunocell Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immunocell Therapy Market Size (2019-2030)

9.2 Latin America Immunocell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Immunocell Therapy Market Size by Country (2019-2024)

9.4 Latin America Immunocell Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immunocell Therapy Market Size (2019-2030)

10.2 Middle East & Africa Immunocell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Immunocell Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Immunocell Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Immunocell Therapy Introduction

11.1.4 Novartis Revenue in Immunocell Therapy Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Detail

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences Immunocell Therapy Introduction

11.2.4 Gilead Sciences Revenue in Immunocell Therapy Business (2019-2024)

11.2.5 Gilead Sciences Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Detail

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Immunocell Therapy Introduction

11.3.4 Bristol-Myers Squibb Revenue in Immunocell Therapy Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 J & J

11.4.1 J & J Company Detail

11.4.2 J & J Business Overview

11.4.3 J & J Immunocell Therapy Introduction

11.4.4 J & J Revenue in Immunocell Therapy Business (2019-2024)

11.4.5 J & J Recent Development

11.5 JW Therapeutics

11.5.1 JW Therapeutics Company Detail

11.5.2 JW Therapeutics Business Overview

11.5.3 JW Therapeutics Immunocell Therapy Introduction

11.5.4 JW Therapeutics Revenue in Immunocell Therapy Business (2019-2024)

11.5.5 JW Therapeutics Recent Development

11.6 FOSUNKite

11.6.1 FOSUNKite Company Detail

11.6.2 FOSUNKite Business Overview

11.6.3 FOSUNKite Immunocell Therapy Introduction

11.6.4 FOSUNKite Revenue in Immunocell Therapy Business (2019-2024)

11.6.5 FOSUNKite Recent Development

11.7 CARsgen Therapeutics (Pipeline)

11.7.1 CARsgen Therapeutics (Pipeline) Company Detail

11.7.2 CARsgen Therapeutics (Pipeline) Business Overview

11.7.3 CARsgen Therapeutics (Pipeline) Immunocell Therapy Introduction

11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.7.5 CARsgen Therapeutics (Pipeline) Recent Development

11.8 Autolus Therapeutics(Pipeline)

11.8.1 Autolus Therapeutics(Pipeline) Company Detail

11.8.2 Autolus Therapeutics(Pipeline) Business Overview

11.8.3 Autolus Therapeutics(Pipeline) Immunocell Therapy Introduction

11.8.4 Autolus Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.8.5 Autolus Therapeutics(Pipeline) Recent Development

11.9 Sorrento Therapeutics(Pipeline)

11.9.1 Sorrento Therapeutics(Pipeline) Company Detail

11.9.2 Sorrento Therapeutics(Pipeline) Business Overview

11.9.3 Sorrento Therapeutics(Pipeline) Immunocell Therapy Introduction

11.9.4 Sorrento Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.9.5 Sorrento Therapeutics(Pipeline) Recent Development

11.10 Mustang Bio(Pipeline)

11.10.1 Mustang Bio(Pipeline) Company Detail

11.10.2 Mustang Bio(Pipeline) Business Overview

11.10.3 Mustang Bio(Pipeline) Immunocell Therapy Introduction

11.10.4 Mustang Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.10.5 Mustang Bio(Pipeline) Recent Development

11.11 Bluebird Bio(Pipeline)

11.11.1 Bluebird Bio(Pipeline) Company Detail

11.11.2 Bluebird Bio(Pipeline) Business Overview

11.11.3 Bluebird Bio(Pipeline) Immunocell Therapy Introduction

11.11.4 Bluebird Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.11.5 Bluebird Bio(Pipeline) Recent Development

11.12 Cellectis(Pipeline)

11.12.1 Cellectis(Pipeline) Company Detail

11.12.2 Cellectis(Pipeline) Business Overview

11.12.3 Cellectis(Pipeline) Immunocell Therapy Introduction

11.12.4 Cellectis(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.12.5 Cellectis(Pipeline) Recent Development

11.13 Allogene Therapeutics(Pipeline)

11.13.1 Allogene Therapeutics(Pipeline) Company Detail

11.13.2 Allogene Therapeutics(Pipeline) Business Overview

11.13.3 Allogene Therapeutics(Pipeline) Immunocell Therapy Introduction

11.13.4 Allogene Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.13.5 Allogene Therapeutics(Pipeline) Recent Development

11.14 Celyad(Pipeline)

11.14.1 Celyad(Pipeline) Company Detail

11.14.2 Celyad(Pipeline) Business Overview

11.14.3 Celyad(Pipeline) Immunocell Therapy Introduction

11.14.4 Celyad(Pipeline) Revenue in Immunocell Therapy Business (2019-2024)

11.14.5 Celyad(Pipeline) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

CARsgen Therapeutics (Pipeline)

Autolus Therapeutics(Pipeline)

Sorrento Therapeutics(Pipeline)

Mustang Bio(Pipeline)

Bluebird Bio(Pipeline)

Cellectis(Pipeline)

Allogene Therapeutics(Pipeline)

Celyad(Pipeline)

List of Tables

Table 1. Global Immunocell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Chimeric Antigen Receptor (CAR) T Cell Therapy

Table 3. Key Players of Natural Killer (NK) Cell Therapy

Table 4. Key Players of Others

Table 5. Global Immunocell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Immunocell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Immunocell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Immunocell Therapy Market Share by Region (2019-2024)

Table 9. Global Immunocell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Immunocell Therapy Market Share by Region (2025-2030)

Table 11. Immunocell Therapy Market Trends

Table 12. Immunocell Therapy Market Drivers

Table 13. Immunocell Therapy Market Challenges

Table 14. Immunocell Therapy Market Restraints

Table 15. Global Immunocell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Immunocell Therapy Market Share by Players (2019-2024)

Table 17. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2023)

Table 18. Ranking of Global Top Immunocell Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Immunocell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Immunocell Therapy Product Solution and Service

Table 22. Date of Enter into Immunocell Therapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Immunocell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Immunocell Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Immunocell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Immunocell Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Immunocell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Immunocell Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Immunocell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Immunocell Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Immunocell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Immunocell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Immunocell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Immunocell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Immunocell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Immunocell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Immunocell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Immunocell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Immunocell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Immunocell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Immunocell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Novartis Company Detail

Table 48. Novartis Business Overview

Table 49. Novartis Immunocell Therapy Product

Table 50. Novartis Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 51. Novartis Recent Development

Table 52. Gilead Sciences Company Detail

Table 53. Gilead Sciences Business Overview

Table 54. Gilead Sciences Immunocell Therapy Product

Table 55. Gilead Sciences Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 56. Gilead Sciences Recent Development

Table 57. Bristol-Myers Squibb Company Detail

Table 58. Bristol-Myers Squibb Business Overview

Table 59. Bristol-Myers Squibb Immunocell Therapy Product

Table 60. Bristol-Myers Squibb Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 61. Bristol-Myers Squibb Recent Development

Table 62. J & J Company Detail

Table 63. J & J Business Overview

Table 64. J & J Immunocell Therapy Product

Table 65. J & J Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 66. J & J Recent Development

Table 67. JW Therapeutics Company Detail

Table 68. JW Therapeutics Business Overview

Table 69. JW Therapeutics Immunocell Therapy Product

Table 70. JW Therapeutics Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 71. JW Therapeutics Recent Development

Table 72. FOSUNKite Company Detail

Table 73. FOSUNKite Business Overview

Table 74. FOSUNKite Immunocell Therapy Product

Table 75. FOSUNKite Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 76. FOSUNKite Recent Development

Table 77. CARsgen Therapeutics (Pipeline) Company Detail

Table 78. CARsgen Therapeutics (Pipeline) Business Overview

Table 79. CARsgen Therapeutics (Pipeline) Immunocell Therapy Product

Table 80. CARsgen Therapeutics (Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 81. CARsgen Therapeutics (Pipeline) Recent Development

Table 82. Autolus Therapeutics(Pipeline) Company Detail

Table 83. Autolus Therapeutics(Pipeline) Business Overview

Table 84. Autolus Therapeutics(Pipeline) Immunocell Therapy Product

Table 85. Autolus Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 86. Autolus Therapeutics(Pipeline) Recent Development

Table 87. Sorrento Therapeutics(Pipeline) Company Detail

Table 88. Sorrento Therapeutics(Pipeline) Business Overview

Table 89. Sorrento Therapeutics(Pipeline) Immunocell Therapy Product

Table 90. Sorrento Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 91. Sorrento Therapeutics(Pipeline) Recent Development

Table 92. Mustang Bio(Pipeline) Company Detail

Table 93. Mustang Bio(Pipeline) Business Overview

Table 94. Mustang Bio(Pipeline) Immunocell Therapy Product

Table 95. Mustang Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 96. Mustang Bio(Pipeline) Recent Development

Table 97. Bluebird Bio(Pipeline) Company Detail

Table 98. Bluebird Bio(Pipeline) Business Overview

Table 99. Bluebird Bio(Pipeline) Immunocell Therapy Product

Table 100. Bluebird Bio(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 101. Bluebird Bio(Pipeline) Recent Development

Table 102. Cellectis(Pipeline) Company Detail

Table 103. Cellectis(Pipeline) Business Overview

Table 104. Cellectis(Pipeline) Immunocell Therapy Product

Table 105. Cellectis(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 106. Cellectis(Pipeline) Recent Development

Table 107. Allogene Therapeutics(Pipeline) Company Detail

Table 108. Allogene Therapeutics(Pipeline) Business Overview

Table 109. Allogene Therapeutics(Pipeline) Immunocell Therapy Product

Table 110. Allogene Therapeutics(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 111. Allogene Therapeutics(Pipeline) Recent Development

Table 112. Celyad(Pipeline) Company Detail

Table 113. Celyad(Pipeline) Business Overview

Table 114. Celyad(Pipeline) Immunocell Therapy Product

Table 115. Celyad(Pipeline) Revenue in Immunocell Therapy Business (2019-2024) & (US$ Million)

Table 116. Celyad(Pipeline) Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immunocell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Immunocell Therapy Market Share by Type: 2023 VS 2030

Figure 3. Chimeric Antigen Receptor (CAR) T Cell Therapy Features

Figure 4. Natural Killer (NK) Cell Therapy Features

Figure 5. Others Features

Figure 6. Global Immunocell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Immunocell Therapy Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Immunocell Therapy Report Years Considered

Figure 12. Global Immunocell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Immunocell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Immunocell Therapy Market Share by Region: 2023 VS 2030

Figure 15. Global Immunocell Therapy Market Share by Players in 2023

Figure 16. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Immunocell Therapy Revenue in 2023

Figure 18. North America Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Immunocell Therapy Market Share by Country (2019-2030)

Figure 20. United States Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Immunocell Therapy Market Share by Country (2019-2030)

Figure 24. Germany Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Immunocell Therapy Market Share by Region (2019-2030)

Figure 32. China Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Immunocell Therapy Market Share by Country (2019-2030)

Figure 40. Mexico Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Immunocell Therapy Market Share by Country (2019-2030)

Figure 44. Turkey Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Immunocell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Novartis Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 47. Gilead Sciences Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 49. J & J Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 50. JW Therapeutics Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 51. FOSUNKite Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 52. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 53. Autolus Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 54. Sorrento Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 55. Mustang Bio(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 56. Bluebird Bio(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 57. Cellectis(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 58. Allogene Therapeutics(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 59. Celyad(Pipeline) Revenue Growth Rate in Immunocell Therapy Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Heavy Ion Radiotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-9J14338

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global Radioisotope Therapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14H14175

Sun Oct 06 00:00:00 UTC 2024

Add to Cart

Global Microwave Tumor Ablation System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22N12035

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Hematologic Malignancies Detection Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20M14708

Mon Sep 02 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions